CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases

Acta Pharmacologica Sinica, Published online: 03 September 2020; doi:10.1038/s41401-020-00510-6CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases

http://feeds.nature.com/~r/aps/rss/current/~3/S53lNrVm6Sg/s41401-020-00510-6

Source: Acta Pharmacologica Sinica - September 2, 2020 Category: Drugs & Pharmacology Authors: Xue-zhi Yang Wei Wei Source Type: research

More News: Drugs & Pharmacology